Grandien A - Search Results

1

Expression of the long form of human FLIP by retroviral gene transfer of hemopoietic stem cells exacerbates experimental autoimmune encephalomyelitis.

Djerbi M, Abdul-Majid KB, Abedi-Valugerdi M, Olsson T, Harris RA, Grandien A. Djerbi M, et al. Among authors: grandien a. J Immunol. 2003 Feb 15;170(4):2064-73. doi: 10.4049/jimmunol.170.4.2064. J Immunol. 2003. PMID: 12574377

2

Simultaneous expression and detection of multiple retroviral constructs in haematopoietic cells after bone marrow transplantation.

Nyakeriga AM, Djerbi M, Malinowski MM, Grandien A. Nyakeriga AM, et al. Among authors: grandien a. Scand J Immunol. 2005 Jun;61(6):545-50. doi: 10.1111/j.1365-3083.2005.01607.x. Scand J Immunol. 2005. PMID: 15963049 Free article.

3

Participation of FLIP, RIP and Bcl-x(L) in Fas-mediated T-cell death.

Djerbi M, Malinowski MM, Yagita H, Zhivotovsky B, Grandien A. Djerbi M, et al. Among authors: grandien a. Scand J Immunol. 2007 Oct;66(4):410-21. doi: 10.1111/j.1365-3083.2007.01957.x. Scand J Immunol. 2007. PMID: 17850585 Free article.

4

Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different flip isoforms.

Djerbi M, Darreh-Shori T, Zhivotovsky B, Grandien A. Djerbi M, et al. Among authors: grandien a. Scand J Immunol. 2001 Jul-Aug;54(1-2):180-9. doi: 10.1046/j.1365-3083.2001.00941.x. Scand J Immunol. 2001. PMID: 11439165 Free article.

5

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.

Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A. Djerbi M, et al. Among authors: grandien a. J Exp Med. 1999 Oct 4;190(7):1025-32. doi: 10.1084/jem.190.7.1025. J Exp Med. 1999. PMID: 10510092 Free PMC article.

6

Upregulation of the apoptosis regulators cFLIP, CD95 and CD95 ligand in peripheral blood mononuclear cells in relapsing-remitting multiple sclerosis.

Gomes AC, Jönsson G, Mjörnheim S, Olsson T, Hillert J, Grandien A. Gomes AC, et al. Among authors: grandien a. J Neuroimmunol. 2003 Feb;135(1-2):126-34. doi: 10.1016/s0165-5728(02)00437-x. J Neuroimmunol. 2003. PMID: 12576232

7

A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.

Screpanti V, Wallin RP, Ljunggren HG, Grandien A. Screpanti V, et al. Among authors: grandien a. J Immunol. 2001 Aug 15;167(4):2068-73. doi: 10.4049/jimmunol.167.4.2068. J Immunol. 2001. PMID: 11489989

8

Host strain-dependent difference in susceptibility in a rat model of herpes simplex type 1 encephalitis.

Bereczky-Veress B, Lidman O, Sabri F, Bednar I, Granath F, Bergström T, Spenger C, Grandien A, Olsson T, Piehl F, Diez M, Sköldenberg B. Bereczky-Veress B, et al. Among authors: grandien a. J Neurovirol. 2008 Apr;14(2):102-18. doi: 10.1080/13550280701883832. J Neurovirol. 2008. PMID: 18444082

9

High level of cFLIP correlates with resistance to death receptor-induced apoptosis in bladder carcinoma cells.

Jönsson G, Paulie S, Grandien A. Jönsson G, et al. Among authors: grandien a. Anticancer Res. 2003 Mar-Apr;23(2B):1213-8. Anticancer Res. 2003. PMID: 12820373

10

NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy.

Hayakawa Y, Screpanti V, Yagita H, Grandien A, Ljunggren HG, Smyth MJ, Chambers BJ. Hayakawa Y, et al. Among authors: grandien a. J Immunol. 2004 Jan 1;172(1):123-9. doi: 10.4049/jimmunol.172.1.123. J Immunol. 2004. PMID: 14688317

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters